<?xml-model href='http://www.tei-c.org/release/xml/tei/custom/schema/relaxng/tei_all.rng' schematypens='http://relaxng.org/ns/structure/1.0'?><TEI xmlns="http://www.tei-c.org/ns/1.0">
	<teiHeader>
		<fileDesc>
			<titleStmt><title level='a'>Direct phosphorylation of HY5 by SPA kinases to regulate photomorphogenesis in Arabidopsis</title></titleStmt>
			<publicationStmt>
				<publisher></publisher>
				<date>06/01/2021</date>
			</publicationStmt>
			<sourceDesc>
				<bibl> 
					<idno type="par_id">10249098</idno>
					<idno type="doi">10.1111/nph.17332</idno>
					<title level='j'>New Phytologist</title>
<idno>0028-646X</idno>
<biblScope unit="volume">230</biblScope>
<biblScope unit="issue">6</biblScope>					

					<author>Wenli Wang</author><author>Inyup Paik</author><author>Junghyun Kim</author><author>Xilin Hou</author><author>Sibum Sung</author><author>Enamul Huq</author>
				</bibl>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract><ab><![CDATA[Elongated hypocotyl5 (HY5) is a key transcription factor that promotes photomorphogenesis. Constitutive photomorphogenic1 (COP1)-Suppressor of phytochrome A-105 (SPA) E3 ubiquitin ligase complex promotes ubiquitination and degradation of HY5 to repress photomorphogenesis in darkness. HY5 is also regulated by phosphorylation at serine 36 residue. However, the kinase responsible for phosphorylation of HY5 remains unknown.Here, using extensive in vitro and in vivo biochemical, genetic, and photobiological techniques, we have identified a new kinase that phosphorylates HY5 and demonstrated the significance of phosphorylation of HY5 in Arabidopsis thaliana.We show that SPA proteins are the missing kinases necessary for HY5 phosphorylation. SPAs can directly phosphorylate HY5 in vitro, and the phosphorylated HY5 is absent in the spaQ background in vivo. We also demonstrate that the unphosphorylated HY5 interacts strongly with both COP1 and SPA1 and is the preferred substrate for degradation, whereas the phosphorylated HY5 is more stable in the dark. In addition, the unphosphorylated HY5 actively binds to the target promoters and is the physiologically more active form. Consistently, the transgenic plants expressing the unphosphorylated form of HY5 display enhanced photomorphogenesis.Collectively, our study revealed the missing kinase responsible for direct phosphorylation of HY5 that fine-tunes its stability and activity to regulate photomorphogenesis.]]></ab></abstract>
		</profileDesc>
	</teiHeader>
	<text><body xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Light is a key environmental factor that influences diverse developmental processes throughout the entire plant life cycle <ref type="bibr">(Whitelam &amp; Halliday, 2007)</ref>. Plants have evolved four classes of photoreceptors to monitor the surrounding light conditions: red/far-red light-sensing phytochromes, blue/ultraviolet (UV)A light-sensing cryptochromes and phototropins, and UVB lightsensing UVR8 <ref type="bibr">(Chen et al., 2004;</ref><ref type="bibr">Paik &amp; Huq, 2019)</ref>. Interestingly, all the light signals perceived by different photoreceptors converge to a downstream transcription factor elongated hypocotyl5 (HY5) to control diverse growth programs <ref type="bibr">(Gangappa &amp; Botto, 2016)</ref>. For example, dark-grown Arabidopsis seedlings undergo skotomorphogenesis, displaying closed, yellowish cotyledons, and long hypocotyls. Upon light irradiation, seedlings undergo photomorphogenesis, which includes open, wide and green cotyledons, and short hypocotyls <ref type="bibr">(Gommers &amp; Monte, 2018)</ref>. The dark-to-light transition mainly causes the accumulation of HY5 proteins and then triggers cascades of downstream gene expressions. Indeed, HY5 binds to nearly one-third of the Arabidopsis genes <ref type="bibr">(Lee et al., 2007;</ref><ref type="bibr">Gangappa &amp; Botto, 2016;</ref><ref type="bibr">Burko et al., 2020)</ref> and regulates a wide range of plant developmental programs, including flowering time, Chl and anthocyanin biosynthesis, primary and lateral root development, and shade and high-temperature responses <ref type="bibr">(Oyama et al., 1997;</ref><ref type="bibr">Ang et al., 1998;</ref><ref type="bibr">Holm et al., 2002;</ref><ref type="bibr">Andronis et al., 2008;</ref><ref type="bibr">Nozue et al., 2015;</ref><ref type="bibr">Gangappa &amp; Botto, 2016)</ref>.</p><p>The level of HY5 protein is regulated by constitutive photo-morphogenic1 (COP1)-suppressor of phytochrome A-105 (SPA) E3 ubiquitin ligase complex <ref type="bibr">(Hoecker, 2017)</ref>. Both COP1 and SPA are crucial repressors of photomorphogenesis. COP1 protein is enriched in nucleus in the dark and depleted from nucleus in the light <ref type="bibr">(Subramanian et al., 2004;</ref><ref type="bibr">Pac &#305;n et al., 2014;</ref><ref type="bibr">Balcerowicz et al., 2017)</ref>. Thus, in darkness, COP1-SPA complex induces ubiquitination and degradation of HY5 and possibly other positive transcription factors in the nucleus <ref type="bibr">(Hoecker, 2017;</ref><ref type="bibr">Han et al., 2020)</ref>. However, upon light irradiation, the activity of the COP1-SPA E3 ubiquitin ligase complex is inhibited by photoreceptors <ref type="bibr">(Ordo&#241;ez-Herrera et al., 2015;</ref><ref type="bibr">Sheerin et al., 2015;</ref><ref type="bibr">Xu et al., 2015)</ref>. The reduction of COP1 in the nucleus and the light-induced inhibition of COP1 activity contribute to the accumulation of HY5 and other positive regulators to promote photomorphogenesis.</p><p>The function of COP1 as a RING-type E3 ubiquitin ligase is evolutionarily conserved in higher eukaryotes. It consists of an N-terminal zinc finger, a central coiled-coil (CC), and a C-terminal WD40 repeats domain, which is essential for proper COP1 function <ref type="bibr">(Deng et al., 1992;</ref><ref type="bibr">Han et al., 2020)</ref>. The SPA family of genes are only found in the green lineages. Arabidopsis has four SPA genes (SPA1-SPA4) <ref type="bibr">(Laubinger et al., 2004;</ref><ref type="bibr">Hoecker, 2017)</ref>. The SPA family of proteins also contain the central CC and the C-terminal WD40 repeats domain, which function similar to the respective domains of COP1 <ref type="bibr">(Hoecker et al., 1999)</ref>. In addition, SPA proteins contain an N-terminal serine/threonine (Ser/Thr) kinase domain which was recently found to have kinase activity on phytochrome interacting factors (PIF1 and PIF4), key negative regulators of photomorphogenesis <ref type="bibr">(Paik et al., 2019;</ref><ref type="bibr">Lee et al., 2020)</ref>. SPA1 and COP1 can interact with each other through their CC domains. SPA proteins are important for COP1 function: the presence of SPA proteins can enhance the activity of COP1 in vitro and in vivo <ref type="bibr">(Saijo et al., 2003;</ref><ref type="bibr">Seo et al., 2003)</ref>. Both cop1 and spaQ (spa1spa2spa3spa4 quadruple) mutants exhibit constitutive photomorphogenesis in the darkness. In plants, COP1 forms multiple complexes with SPA proteins in a tissue and developmental-stage-specific manner. Previous studies showed that the WD40 repeat domain of both COP1 and SPA1 interacts with the N-terminal domain of HY5, and the COP1-SPA complex promotes ubiquitination and subsequent degradation of HY5 and many other transcription factors in darkness <ref type="bibr">(Torii et al., 1998;</ref><ref type="bibr">Hardtke et al., 2000;</ref><ref type="bibr">Saijo et al., 2003;</ref><ref type="bibr">Hoecker, 2017;</ref><ref type="bibr">Han et al., 2020;</ref><ref type="bibr">Kathare et al., 2020)</ref>.</p><p>In addition to COP1-SPA-mediated degradation in darkness, HY5 is also regulated by phosphorylation at serine 36 residue <ref type="bibr">(Hardtke et al., 2000)</ref>. The unphosphorylated form of HY5 interacts more strongly with COP1 and is preferentially degraded in the dark, but it becomes more abundant in light-grown seedlings <ref type="bibr">(Hardtke et al., 2000)</ref>. Because serine 36 is located within a conserved Casein Kinase II (CKII) phosphorylation site, these authors also hypothesized that a light-regulated CKII might be responsible for phosphorylation of HY5. However, the identity of the kinase remained elusive. Given the known physical interactions and the recently described SPA kinase activity, it prompted us to examine whether HY5 is a new substrate of SPA kinase. Here, we provide in vitro and in vivo evidence supporting the conclusion that SPA proteins are the missing kinase for HY5 phosphorylation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Plant materials and growth conditions</head><p>Wild-type (WT) Col-0, various mutants, and transgenic plants in the Col-0 background of A. thaliana were used in this study, unless indicated otherwise. Plants were grown in soil under 24 h light at 22 AE 0.5&#176;C. Tandem affinity purification-SPA1, luciferase (LUC)-SPA1/spaQ, and LUC-mSPA1/spaQ transgenic plants were reported previously <ref type="bibr">(Paik et al., 2019)</ref>. To generate HY5, HY5-S36A, and HY5-S36D transgenic lines, the HY5 36 th serine (AGC) was changed into alanine (GCC) and aspartic acid (GAC), respectively, using a Quickchange II site-directed mutagenesis kit (200523; Agilent, Cedar Creek, TX, USA) and cloned into pB7FWG vectors, then transformed into hy5-215, spaQ, and WT backgrounds. The transformants were selected in the presence of Basta. Multiple transgenic lines with the same overexpressed HY5 proteins were used for analyses.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Vector constructions and protein purification</head><p>Maltose-binding protein (MBP)-COP1 and MBP-SPA1 were prepared as described previously <ref type="bibr">(Xu et al., 2014;</ref><ref type="bibr">Paik et al., 2019)</ref>. For purification of glutathione S-transferase (GST)-HY5 and its mutant proteins, HY5, HY5-S36A, and HY5-S36D were cloned into pGEX4T-1. Each plasmid was transformed into BL21(DE3) cells. Protein expression was induced under 16&#176;C for overnight with 0.1 mM isopropyl b-D-1-thiogalactopyranoside. Collected cells were sonicated in binding buffer (100 mM Tris-Cl, pH 7.5, 150 mM sodium chloride (NaCl), 0.2% Tergitol NP-40, 19 Protease inhibitor cocktail, and 1 mM phenylmethylsulfonyl fluoride (PMSF)) and purified using GST agarose beads (20211; Pierce Biotechnology Inc., Waltham, MA, USA). Proteins were eluted with the elution buffer (Tris-Cl, pH 7.5, 150 mM NaCl, 1 mM, 10 mM glutathione, 10% Tergitol NP-40, 10% glycerol, 1 mM PMSF, 19 protease inhibitor cocktail) into separate fractions. The eluted proteins were analyzed on sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) gel and used for kinase assays and pull-down assay.</p><p>For cloning of the pYES2-(m)SPA1-green fluorescent protein (GFP) expression vectors, the full-length SPA1 and mSPA1 sequences were PCR amplified using the SPA1_fwd and SPA1_rev primers (Supporting Information Table <ref type="table">S1</ref>). The GFP sequence was separately PCR amplified using GFP_fwd 1 and GFP_rev primers (Table <ref type="table">S1</ref>). The expression vector pYES2 was initially digested with Eco53kI and gel purified. From each DNA (SPA1, GFP, and digested pYES2) 40 fmol was combined with a Gibson assembly master mix (E2611S; NEB, Ipswich, MA, USA) and ligated according to the manufacturer's instruction. Cloned pYES2-(m)SPA1-GFP was transformed and purified in Saccharomyces cerevisiae as previously described for the pYES2-PHYB-GFP purification method <ref type="bibr">(Paik et al., 2019)</ref>.</p><p>For cloning of pYES2-SPA2(3/4)-GFP expression vectors, the full-length SPA2(3/4) sequences were PCR amplified using SPA2 (3/4)_fwd and SPA2(3/4)_rev primers (Table <ref type="table">S1</ref>). The expression vector pYES2 with GFP tag was PCR amplified from pYES2-SPA1-GFP vector using GFP_fwd 2 and pYES2_rev primers (Table <ref type="table">S1</ref>). SPA2(3/4) and pYES2-GFP were then combined with a Gibson assembly master mix. Cloned pYES2-SPA2 (3/4)-GFP was transformed and purified from S. cerevisiae as already described herein.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>In vitro kinase assay</head><p>For SPA1 kinase assay, about 500 ng of Pichia pastoris purified SPA1-strep and 1 lg of Escherichia coli purified GST-HY5 or GST-HY5-S36A fusion proteins were used. For mSPA1 kinase assay, SPA1-GFP and mSPA1-GFP were purified from S. cerevisiae as described earlier herein. For SPA2(3/4) kinase assay, SPA2(3/4)-GFP were purified from S. cerevisiae as described earlier herein. All kinase assays were performed in a kinase buffer (50 mM Tris, pH 7.5, 4 mM b-mercaptoethanol, 1 mM EDTA, 10 mM magnesium chloride). Phosphorus-32 radiolabeled gamma-ATP (BLU502A; Perkin Elmer, Waltham, MA, USA) was added to the reaction and incubated at 28&#176;C for 1 h, unless indicated otherwise. SDS sample buffer (69) was added to stop the reaction, and the boiled proteins were separated on SDS-PAGE gel. The gels were dried and exposed to a phosphor screen and then scanned with Typhoon FLA 9500 (GE Healthcare, Chicago, IL, USA).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>HY5 mobility shift assay</head><p>To observe GFP-HY5 mobility shift in Col-0 and spaQ, total protein was separated in a 10 cm 9 10.5 cm 7% SDS-PAGE or 4-15% gradient SDS-PAGE (456-1084; Bio-Rad) or 8% SDS-PAGE gel containing 15-20 lM Phos-tag acrylamide (AAL-107; Wako Pure Chemical Industries, Osaka, Japan). For regular SDS-PAGE gel, total proteins were extracted from 4-d-old lightgrown or dark-grown seedlings with extraction buffer (100 mM Tris&#193;HCl (pH 6.8), 20% glycerol, 5% SDS, 20 mM dithiothreitol, 1 mM PMSF, 19 protease inhibitor, and 100 lM bortezomib). The extracts were cleared by centrifugation and then incubated with or without 400 U ml &#192;1 alkaline phosphatase, calf intestinal (CIP, M0290; NEB) at 37&#176;C for 30 min. The reaction mixtures were terminated by adding 69 SDS loading buffer and boiling at 99&#176;C for 10 min. Immunoblotting analyses were performed with anti-GFP and anti-Tubulin antibodies. For Phostag gel, immunoprecipitated proteins were treated with or without CIP, then analyzed by immunoblotting. The in vivo co-immunoprecipitation (co-IP) assay is described later.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Protein extraction and Western blot analyses</head><p>To analyze HY5 abundance in dark-to-light and light-to-dark transition, seeds were surface sterilized and grown in the dark or continuous white light (100 lmol m &#192;2 s &#192;1 ) for 4 d or followed the respective conditions (continues dark or light treatment, different hours of dark or light treatment, 100 lmol m &#192;2 s &#192;1 ) as described in the figure legends. To analyze HY5 abundance in mutants and transgenic lines, seedlings were grown in continuous dark for 4 d. To analyze (m)SPA1 abundance in LUC-SPA1/ spaQ and LUC-mSPA1/spaQ transgenic lines, seedlings were grown in continuous dark for 4 d. For total protein extraction, whole seedlings were collected and ground in 100 ll denaturing extraction buffer (100 mM Tris pH 7.5, 1 mM EDTA, 8 M urea, 19 protease inhibitor cocktail (59; Sigma-Aldrich), 2 mM PMSF) and cleared by centrifugation at 20 200 g for 10 min at 4&#176;C. Samples were boiled for 10 min with 69 SDS sample buffer and separated on a 10% SDS-PAGE gel, blotted onto polyvinylidene difluoride membranes, and probed with corresponding antibodies. Antibodies used in these studies are anti-HY5 (R1245-2; Abiocode Inc., Agoura Hills, CA, USA), anti-GFP (ab6556 for immunoprecipitation; Abcam, Cambridge, MA, USA), anti-LUC (A11120; Thermofisher, Waltham, MA, USA), anti-Tubulin antibodies (BML-PW8770-0025; Enzo Life Sciences, Farmingdale, NY, USA). Secondary horseradish peroxidase (HRP)bound antibodies were visualized with Super Signal West Pico Chemiluminescent substrate (Pierce Biotechnology Inc.) and developed with an X-ray film or GBox-F3 Syngene Imager. The intensity of the HY5 and Tubulin bands from three independent blots was quantified using IMAGEJ software (US National Institutes of Health, Bethesda, MD, USA), and the HY5 values were divided by the Tubulin values to generate a ratio for each sample. The HY5 level in the light (L) or at 12 h light was set to 1 from these ratios, respectively, and the relative values of the other time points were then calculated. These relative values are shown as line graphs in each figure in addition to the blots. Student's t-test was used to analyze the significant difference.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>In vitro pull-down assay</head><p>For in vitro pull-down assays, MBP-COP1, MBP-SPA1, GST-HY5, GST-HY5-S36A and GST-HY5-S36D fusion proteins were prepared as described previously. A 1 lg protein sample was used for each of them. All protein combinations were incubated with 20 ml of amylose resin in the binding buffer (50 mM Tris-Cl, pH 7.5, 150 mM NaCl, 0.6% Tween 20, and 1 mM DTT) for 3 h. The beads were collected and washed six times with 5 min of rotation each time in binding buffer. The bound HY5 was detected by anti-GST-HRP conjugate (RPN1236; GE Healthcare Bio-Sciences). Membranes were developed and visualized as described earlier. The intensity of the GST-HY5 band from three independent blots was quantified using IMAGEJ software and normalized to added COP1 and SPA1 proteins. Further, the ratio of the first clear band was set to 1 for each blot.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>In vivo co-immunoprecipitation assay</head><p>For Co-IP experiments, homozygous HY5-GFP, HY5-S36A and HY5-S36D transgenic seedlings were grown in dark for 4 d and then treated with 40 lM bortezomib (LC Laboratories, Woburn, MA, USA) for at least 4 h. Total proteins were extracted from 1 g tissue with 1 ml protein extraction buffer. After 15 min centrifugation at 16 000 g at 4&#176;C in darkness, 100 ll supernatant of each sample was reserved as total, and the remainder was incubated with Dynabeads Protein A (10002D; Life Technologies Co., Carlsbad, CA, USA) bound with anti-GFP antibody (ab9110; Abcam). Twenty microliter Dynabeads with 1 lg antibody were used for individual sample. After 2 h incubation in the dark at 4&#176;C, beads were washed three times with 1 ml protein extraction buffer with 0.2% NP40. Immuno-precipitated proteins were analyzed by immunoblotting.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RNA extraction and quantitative RT-PCR</head><p>The quantitative reverse transcription (RT)-PCR (qRT-PCR) analysis was performed as described with minor variations <ref type="bibr">(Shor et al., 2017)</ref>. Total RNA was isolated from 4-d-old dark-grown seedlings followed by 3 h light treatment or from 4-d-old light-grown seedlings using the Spectrum Plant Total RNA Kit (Sigma-Aldrich). Total RNA (1 lg) was treated with DNase I to eliminate genomic DNA and then reverse transcribed using SuperScript III (Life Technologies) as per the manufacturer's protocol. Real-time PCR was performed using the Power SYBR Green RT-PCR Reagents Kit (Applied Biosystems, Foster City, CA, USA) in a 7900HT Fast Real-Time PCR machine (Applied Biosystems). PP2A was used as a control to normalize the expression data. The resulting cycle threshold values were used to calculate the levels of expression of different genes relative to PP2A, as suggested by the manufacturer (Applied Biosystems). The primer sequences used for qRT-PCR are listed in Table <ref type="table">S1</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Chromatin immunoprecipitation-quantitative PCR assay</head><p>Three biological replicates of HY5 and HY5-S36A and HY5-S36D seedlings grown in the dark for 4 d and moved to simulated white light for 3 h were used for chromatin immunoprecipitation (ChIP)-quantitative PCR (qPCR) analysis. ChIP experiments were performed as previously described <ref type="bibr">(Shor et al., 2017)</ref>. Anti-GFP (ab6556 for immunoprecipitation; Abcam) antibody was used for immunoprecipitation. After elution, reversing crosslinks, and DNA purification, the amount of each precipitated DNA fragment was detected by real-time qPCR using the specific primers listed in Table <ref type="table">S1</ref>. Three biological replicates were performed, and three technical repeats were carried out for each biological replicate. Student's t-test was used to analyze the significant difference.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Measurement of hypocotyl lengths</head><p>For the measurement of hypocotyl length under dark, red light (Rc), and far-red light (FRc) with different intensities, images of 150 seedlings (30 seedlings for each line with three independent biological replicates) at each light intensity condition were taken and then measured using the publicly available IMAGEJ software (<ref type="url">http://rsb.info.nih.gov/ij/</ref>). Seeds were plated on Murashige &amp; Skoog (MS) medium without sugar and kept in the dark for 3 d at 4&#176;C. Seeds were then exposed to 3 h of white light (100 lmol m &#192;2 s &#192;1 ) to induce germination and then kept in the dark for 21 h. The dark-grown seedlings were exposed to far-red light (34 lmol m &#192;2 s &#192;1 ) for an additional 10 min before being put in darkness. All the other plates were then put in conditions for 3 d as described in the figures. Light fluence rates were measured using a spectroradiometer (model EPP2000; StellarNet, Tampa, FL, USA) as described previously <ref type="bibr">(Shen et al., 2005)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Light treatments</head><p>For Western blot, co-IP, ChIP-qPCR and RT-PCR samples, seeds were surface sterilized and plated on MS growth medium without sucrose on filter paper and kept in the dark for 3 d at 4&#176;C. Seeds were then exposed to 3 h of white light (100 lmol m &#192;2 s &#192;1 ) to induce germination and then put in the respective conditions (continuous dark or light treatment, different hours of dark or light treatment) as described in the figure legends. White light (100 lmol m &#192;2 s &#192;1 ) was used in all light treatment.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SPA1 can directly phosphorylate Serine-36 on HY5 proteins in vitro</head><p>Our recent studies show that SPA1 acts as an Ser/Thr kinase for both PIF1 and PIF4 <ref type="bibr">(Paik et al., 2019;</ref><ref type="bibr">Lee et al., 2020)</ref>. Since COP1-SPA E3 ubiquitin ligase complex interacts with HY5 proteins in the dark to promote its degradation, we hypothesize that HY5 might be a new substrate of SPA kinase. To test whether SPA can phosphorylate HY5 protein, we first purified streptagged full-length SPA1 protein from a eukaryotic expression host (P. pastoris) and GST-tagged HY5 from bacteria (E. coli), and performed an in vitro kinase assay. We found that SPA1 directly phosphorylates HY5 in vitro in a concentration-dependent manner (Fig. <ref type="figure">1a,</ref><ref type="figure">d</ref>). To check if this phosphorylation activity is changed by the incubation time, we conducted the kinase assay over time (Fig. <ref type="figure">1b</ref>). With increasing HY5 protein and incubation time, we observed stronger phosphorylation signals. These results suggest that SPA1 phosphorylates HY5 in a concentration and time-dependent manner (Fig. <ref type="figure">1a,</ref><ref type="figure">b</ref>).</p><p>To map the phosphorylation sites in HY5, we used GST-HY5 to conduct in vitro phosphorylation assays using SPA1 as a kinase and performed mass-spectrometry analyses. These data revealed a single phosphorylation site (Ser-36) under these conditions, which is located at the 36 th serine at the N-terminus of HY5 (Dataset S1). A previous study showed that a deletion of the first 40 amino acids of HY5 completely abolished the interaction with COP1 <ref type="bibr">(Hardtke et al., 2000)</ref>. A 36 amino acid stretch between the 25 th and 60 th residues of HY5 proteins was then defined as a COP1 interacting domain. In addition, HY5 interacts with SPA1 through its N-terminal domain <ref type="bibr">(Saijo et al., 2003)</ref>. Thus, the mapped phosphorylation site of HY5 is within its interaction domain for both COP1 and SPA (Fig. <ref type="figure">1c</ref>). To address the significance of the phosphorylation site, we replaced the Ser-36 with alanine (S36A) or aspartic acid (S36D) to generate nonphosphorylation mutant and phospho-mimicking mutant, respectively. The in vitro kinase assay showed that mutant recombinant protein (HY5-S36A) cannot be phosphorylated by SPA1 (Fig. <ref type="figure">1d</ref>), supporting that Ser-36 residue might be the single phosphorylation site of HY5 under these conditions. SPA1 kinase domain is conserved in SPA1 sequences from multiple plants (Fig. <ref type="figure">S1A</ref>) <ref type="bibr">(Paik et al., 2019)</ref>. The R517 residue in SPA1 is part of a conserved glutamic acid-arginine (Arg) salt bridge that defines eukaryotic protein kinases <ref type="bibr">(Yang et al., 2012)</ref> and has recently been shown to be critical for its biological function <ref type="bibr">(Holtkotte et al., 2016;</ref><ref type="bibr">Paik et al., 2019;</ref><ref type="bibr">Lee et al., 2020)</ref>. To investigate the importance of SPA1-Ser/Thr kinase activity for HY5 phosphorylation, we used the point mutant version of SPA1 (mSPA1) that has the R517E mutation in the kinase domain. The in vitro kinase assay confirmed a significantly reduced phosphorylation activity of mSPA1 on HY5 (Fig. <ref type="figure">1e</ref>). These data collectively suggest that SPA1 is a bona fide kinase for HY5.</p><p>Furthermore, all the SPA proteins contain an N-terminal Ser/ Thr kinase domain (Fig. <ref type="figure">S1A</ref>). To investigate whether other SPAs could phosphorylate HY5, we performed in vitro kinase assays using purified GFP-tagged full-length SPA2 (3/4) protein from a eukaryotic expression host (S. cerevisiae) and GST-tagged HY5 from bacteria (E. coli). The kinase assay results show that SPA2, SPA3, and SPA4 can also directly phosphorylate HY5 (Fig. <ref type="figure">S1B</ref>), suggesting that all four SPAs have redundant kinase activity.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SPAs are necessary for phosphorylation of HY5 in vivo</head><p>To investigate the phosphorylation status of HY5 in vivo, we generated HY5-overexpressing transgenic plants (HY5-GFP) in WT background and purified HY5-GFP proteins from transgenic seedlings grown in the dark or in the light. In immunoblot analysis, we observed band mobility shift on a regular SDS-PAGE gel after treatment with the native CIP in both dark and light-grown seedlings (Figs 2a, S2A,B), indicating that HY5 is phosphorylated under both dark and light conditions.</p><p>To examine the in vivo effect of SPAs on the HY5 phosphorylation, we then generated transgenic plants overexpressing HY5-GFP in spaQ background (HY5-GFP/spaQ). Strikingly, the phosphorylation and band shift of HY5 by CIP treatment observed in WT was completely abolished in the spaQ mutants both grown in the dark and light (Fig. <ref type="figure">2b</ref>). The HY5 phosphorylation status was further examined by utilizing Phos-tag-containing SDS-PAGE gels (Figs 2c, S2C). In WT plants, HY5-GFP showed clear mobility shift after CIP treatment in the presence of &#192;, no protein added; +, protein added; M, a protein marker. (c) Single phosphorylation site of HY5 is located at Ser-36 in its constitutive photomorphogenic1 and SPA1 interacting domain. Ser-36 was then replaced with alanine (S36A) and aspartic acid (S36D) to generate a nonphosphorylation form and a phospho-mimicking form of HY5, respectively. (d) SPA1 protein purified from P. pastoris phosphorylates wild type (WT) HY5 but not the nonphosphorylation mutant of HY5 in vitro (autoradiogram in upper panel). The lower panel shows the protein levels in a Coomassiestained gel. &#192;, no protein added; +, protein added; ++, doubled amount of protein added; M, a protein marker. (e) A conserved amino acid mutation on the SPA1 kinase domain (mSPA1) reduces the phosphorylation activity of SPA1 on HY5 (autoradiogram in upper panel). An in vitro kinase assay was performed using purified SPA1-green fluorescent protein (GFP) and mSPA1-GFP proteins purified from Saccharomyces cerevisiae and glutathione Stransferase-HY5 protein purified from Escherichia coli. The lower panel shows the protein level in a Coomassie-stained gel. &#192;, no protein added; +, protein added; M, a protein marker.</p><p>20 lM Phos-tag (Fig. <ref type="figure">S2C</ref>). However, in spaQ mutant, no mobility shift was observed under these conditions and HY5-GFP showed a faster migrating band than that in WT (Fig. <ref type="figure">2c</ref>), suggesting a complete absence of phosphorylation of HY5 in vivo. Taken together, these results indicate that SPAs are responsible for HY5 phosphorylation in vivo under both light and dark conditions.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SPA1 kinase domain is essential for its biological function</head><p>To confirm the role of SPAs in the regulation of HY5, we measured the level of endogenous HY5 protein in different mutants and transgenic lines grown in the dark for 4 d (Fig. <ref type="figure">S3</ref>). As expected, we hardly detected HY5 protein signals in WT seedlings grown in the dark, whereas HY5 proteins were significantly accumulated in both cop1 and spaQ mutants (Fig. <ref type="figure">S3A</ref>). In spa triple mutants (spa123 and spa124), weaker bands of HY5 protein were detected, indicating that four SPA members have redundant functions in regulating HY5 levels (Fig. <ref type="figure">S3B</ref>). To clarify the biological role of SPA1 kinase activity, we then used the transgenic lines overexpressing similar amounts of SPA1 (LUC-SPA1) and mSPA1 (LUC-mSPA1) in spa quadruple mutants (spaQ) background (Fig. <ref type="figure">S4</ref>). The HY5 level was more reduced by introduction of LUC-SPA1 compared with LUC-mSPA1 in the spaQ background (Fig. <ref type="figure">3a</ref>), suggesting that the reduction in kinase activity of mSPA1 is deficient in degrading HY5 in the dark. This result is also consistent with the LUC-mSPA1 transgenic seedlings phenotype in the dark, which failed to rescue the constitutive photomorphogenesis, whereas LUC-SPA1 can largely rescue the constitutive photomorphogenic phenotype of spaQ (Fig. <ref type="figure">3b,</ref><ref type="figure">c</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>HY5 phosphorylation affects its interaction with COP1 and SPA1</head><p>Degradation of HY5 largely depends on its interaction with COP1-SPA complex in the nucleus <ref type="bibr">(Hardtke et al., 2000;</ref><ref type="bibr">Osterlund et al., 2000;</ref><ref type="bibr">Saijo et al., 2003)</ref>. HY5 interacts with both COP1 and SPA1 through its N-terminal domain <ref type="bibr">(Hardtke et al., 2000;</ref><ref type="bibr">Saijo et al., 2003)</ref>, and the phosphorylation site resides within the interacting domain (Fig. <ref type="figure">1c</ref>). Using plant extracts as a source of kinase and commercially available lambda phosphatase, it was shown that the unphosphorylated form of HY5 interacts with COP1 more strongly than the phosphorylated form does <ref type="bibr">(Hardtke et al., 2000)</ref>. Since we have identified the kinase necessary for phosphorylation of HY5 and also created the phosphonull and phospho-mimic forms of HY5, we therefore examined whether the phosphorylation of HY5 affects its interactions with COP1 and SPA1. To address this, we performed in vitro pulldown assays with purified fusion proteins, MBP-COP1 and MBP-SPA1. Each of the recombinant GST-fused WT HY5, HY5-S36A, and HY5-S36D proteins was precipitated by MBP-COP1 or MBP-SPA1. Interestingly, the results show that the nonphosphorylated form of HY5 (HY5-S36A) protein has a higher affinity to both COP1 and SPA1, whereas the phosphomimicking form of HY5 (HY5-S36D) protein has a significantly lower affinity to both COP1 and SPA1 than with WT HY5 (Fig. <ref type="figure">4a-d</ref>). We also conducted an in vivo co-IP assay with transgenic lines overexpressing similar amounts of HY5-GFP, HY5-S36A-GFP and HY5-S36D-GFP in hy5 mutant background (Fig. <ref type="figure">4e</ref>). When immunoprecipitated using GFP antibody, four times more COP1 protein was co-immunoprecipitated in the HY5-S36A-GFP line than that in the HY5-S36D-GFP line (Fig. <ref type="figure">4e</ref>). Taken together, both in vitro and in vivo data suggest that phosphorylation alters the affinity of HY5 to COP1-SPA complex and may also affect its accumulation and biological functions, as previously shown <ref type="bibr">(Hardtke et al., 2000)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Unphosphorylated HY5 degrades and accumulates faster than phosphorylated HY5</head><p>As a key positive regulator in seedlings photomorphogenesis, HY5 accumulates in response to the light and degrades in the dark <ref type="bibr">(Osterlund et al., 2000)</ref>. Previous studies have shown that the interaction between HY5 and COP1 or SPA1 is required for the degradation of HY5 in a polyubiquitination-dependent manner <ref type="bibr">(Osterlund et al., 2000;</ref><ref type="bibr">Saijo et al., 2003)</ref>. As we observed that phosphorylation alters HY5-interaction affinity to COP1 and SPA1, we hypothesized that different interaction affinity may further affect HY5 stability. To verify our hypothesis, we examined the ubiquitination status of HY5 (S36A/S-36D)-GFP in vivo. WT HY5, HY5-S36A and HY5-S36D proteins were immunoprecipitated from dark-grown transgenic seedlings, pretreated with proteasome inhibitor (bortezomib), and then probed with anti-GFP and anti-Ub antibodies. Strikingly, the HY5-S36A has significantly higher ubiquitination level, whereas HY5-S36D has significantly reduced ubiquitination level compared with WT HY5 (Fig. <ref type="figure">5</ref>).</p><p>We also tested the protein levels of HY5, HY5-S36A and HY5-S36D transgenic seedlings that were grown in continuous light for 4 d and then transferred into dark for several hours (5, 10, 20 h) or grown in continuous dark for 4 d. The result shows that nonphosphorylated HY5 (HY5-S36A) is degraded faster during the light-to-dark transition, whereas the phospho-mimic form of HY5 (HY5-S36D) is more stable, even in the dark (Fig. <ref type="figure">6a,</ref><ref type="figure">b</ref>). Specifically, the degradation rate of nonphosphorylated HY5 was significantly increased after 5 h of dark transition (Fig. <ref type="figure">6b</ref>). On the contrary, the degradation of phospho-mimicking HY5 was not obvious in the first 10 h of dark transition and its degradation was observed only after longer exposure of darkness (Fig. <ref type="figure">6b</ref>). Our results suggest that the nonphosphorylated form of HY5 is the preferred substrate for degradation and the phospho-mimic form of HY5 is not prone to be degraded. This is consistent with our observation as well as a previously published report that the nonphosphorylated form of HY5 has higher binding affinity to COP1 and SPA1 and higher ubiquitination level, whereas the phosphomimic form of HY5 has much lower affinity to both proteins and a lower ubiquitination level <ref type="bibr">(Hardtke et al., 2000)</ref>. These results indicate that the phosphorylation of HY5 results in weak interaction with COP1-SPA complex and subsequent ubiquitination status, making the HY5 proteins more stable in the dark.</p><p>In addition, we compared the accumulation rates of each mutant forms of HY5 during dark-to-light transition (Fig. <ref type="figure">6c,</ref><ref type="figure">d</ref>). The accumulation of HY5 in response to light is very fast, and the accumulation occurs within 1 h of light exposure. It reaches to the peak in 3 h (Fig. <ref type="figure">6d</ref>). The nonphosphorylated form of HY5 appears to be more sensitive to the light irradiation, as it shows relatively rapid and higher HY5 protein accumulation within the first 1 h after light irradiation, even though it is not statistically significant (Fig. <ref type="figure">6d</ref>). Taken together, our results suggest that phosphorylation of HY5 results in an altered response rate to dark and light. As a negative regulator of HY5, SPA1 phosphorylates HY5 and the phosphorylated HY5 remains stable in the dark, which suggests a COP1-SPA-HY5 negative feedback loop may exist. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>HY5 phosphorylation affects its molecular and physiological activity</head><p>Previous studies have reported that phosphorylation can affect the binding affinity of HY5 to its target DNAs in vitro <ref type="bibr">(Hardtke et al., 2000)</ref>. To investigate whether phosphorylation alters the in vivo DNA bindings of HY5, we performed ChIP-qPCR assays. We selected several well-known HY5 target genes (XTH15, EXP2, IAA19, SAUR36 and CHS). Because HY5 protein accumulates to the peak after 3 h of light activation during dark-to-light transition (Fig. <ref type="figure">6d</ref>), we performed ChIP-qPCR with transgenic seedlings grown in the dark for 4 d and then transferred to the light for an additional 3 h. Surprisingly, nonphosphorylated forms of HY5 enriched to the target loci significantly higher than the WT HY5. On the other hand, the phospho-mimic form of HY5 enriched to target loci slightly lower than the WT HY5 (Figs 7a, S5A), indicating that unphosphorylated HY5 has higher affinity to its target DNA, which is largely consistent with a previous report <ref type="bibr">(Hardtke et al., 2000)</ref>.</p><p>To examine whether the altered association of HY5 with its target loci affects their levels of transcript abundance, we then performed real-time qRT-PCR with the three transgenic lines grown under the same condition along with WT and hy5 as controls. Consistent with higher association, the expression of three auxin signaling pathway genes (SAUR36, IAA19 and EXP2) and a growth gene (XTH15), which are known HY5 repressed genes, was strongly repressed in the HY5-S36A line (Figs 7b, S5B). However, HY5-S36D displayed higher expression of some of  <ref type="figure">S5B</ref>). Our data suggest that the phosphorylation of HY5 affects the transcriptional activity of HY5 by changing its binding ability to target loci in vivo. The levels of HY5 protein and me3ssenger RNA were similar among HY5, HY5-S36A, and HY5-S36D lines after 3 h light irradiation or grown in continuous light for 4 d (Figs S6, S7), and all the proteins were similarly stabilized under light (Fig. <ref type="figure">S7</ref>). Therefore, the differences in the association of phosphorylated and unphosphorylated HY5 and transcription of target loci are due to altered HY5 activity, and not due to different levels of expression of transgenes. Furthermore, to check whether the phosphorylation mutants of HY5 result in any phenotypic changes, we measured the hypocotyl length of seedlings of the phosphorylation mutant lines grown under dark for 4 d or continuous red (Rc) or far-red (FRc) light for 4 d with increasing light intensities (Fig. <ref type="figure">8a,</ref><ref type="figure">b</ref>). In both red light and far-red light conditions, hy5 mutant showed relatively longer hypocotyl, which was rescued by overexpressing HY5 protein (Fig. <ref type="figure">8c,</ref><ref type="figure">d</ref>). Notably, the HY5-S36A line showed shorter hypocotyls than others under most of Rc conditions and low intensity of FRc conditions (Fig. <ref type="figure">8a,</ref><ref type="figure">b</ref>), even though all the lines had similar hypocotyl lengths in the dark. HY5-S36A hypocotyl length was strongly reduced once exposed to light. Taken together, our results clearly showed that higher binding affinity of unphosphorylated HY5 is physiologically more active than phosphorylated HY5 in regulating photomorphogenesis, especially during rapid light response.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>HY5 protein plays a pivotal role in photomorphogenesis. Therefore, it is not surprising that a number of HY5 binding targets are involved in diverse developmental processes. In Arabidopsis, more than 60% of early-induced genes by phyA or phyB are HY5 direct targets, which strongly supports the notion that HY5 is one of the high hierarchical regulators of the transcriptional cascade for photomorphogenesis <ref type="bibr">(Gangappa &amp; Botto, 2016)</ref>. The regulation of HY5 by light includes posttranslational modifications such as phosphorylation and poly-ubiquitination that are controlled by phytochromes and COP1-SPA E3 ubiquitin ligase complex. Previous studies have hypothesized that a light-regulated CKII-like kinase might phosphorylate HY5 and regulate its abundance and activity <ref type="bibr">(Hardtke et al., 2000;</ref><ref type="bibr">Gangappa &amp;</ref>  Botto, 2016). Despite the phosphorylation in HY5 was reported &gt; 20 yr ago, the kinase responsible for HY5 phosphorylation remained elusive. Here, we provide a mechanistic view on how HY5 is phosphorylated and ubiquitinated by a cognate kinase-E3 ubiquitin ligase (COP1-SPA) to modulate its regulatory activity in photomorphogenesis (Fig. <ref type="figure">9</ref>).</p><p>In this study, we provide evidence that SPAs are the kinases for HY5 and, thus, regulate its stability and activity. We observed strong phosphorylation signals in in vitro kinase assays, and the phosphorylation of HY5 was significantly reduced in spaQ mutant compared with that in WT in vivo (Figs 1, 2). We also found that SPA1 phosphorylates HY5 through only one phosphorylation site, which is Ser-36 (Fig. <ref type="figure">1d</ref>), which is consistent with a previous report <ref type="bibr">(Hardtke et al., 2000)</ref>. The mutation of this site abolished the phosphorylation of HY5. Previously, CKII was hypothesized to be a likely candidate kinase of HY5 <ref type="bibr">(Hardtke et al., 2000)</ref>. CKII was also shown to be a kinase for PIFs and another positively acting basic helix-loop-helix transcription factor HFR1 <ref type="bibr">(Park et al., 2008;</ref><ref type="bibr">Bu et al., 2011)</ref>. However, the in vitro kinase assay using a kinase-containing fraction of enriched seedling extract in a previous study is not sufficient to conclude that CKII is the kinase <ref type="bibr">(Hardtke et al., 2000)</ref>, given that other components may also exist in the extract. By contrast, we present strong in vitro and in vivo evidence that SPAs are the key kinases necessary for HY5 phosphorylation. <ref type="bibr">Hardtke et al. (2000)</ref> also reported that the kinase activity responsible for HY5 phosphorylation might be regulated by light and that the unphosphorylated HY5 may accumulate more under light for efficient light response. However, we observed phosphorylation of HY5 under both light and dark conditions (Fig. <ref type="figure">2a</ref>). Previously, SPA1 was shown to be recruited by phyB for light-induced PIF1 phosphorylation <ref type="bibr">(Paik et al., 2019)</ref>. Further studies are necessary to dissect whether the SPA-mediated phosphorylation of HY5 is light regulated or not.</p><p>It has been suggested that the kinase domain of SPA1 may provide structural information critical for SPA1 function <ref type="bibr">(Holtkotte et al., 2016)</ref>. SPA1 R517E mutant shows a defect in PIF1 degradation and seed germination in response to light <ref type="bibr">(Paik et al., 2019)</ref>. Similarly, SPA1 R517E (mSPA1) transgenic lines failed to rescue the seedlings' de-etiolation phenotype of spaQ (Fig. <ref type="figure">3b</ref>). Since the Arg 517 in SPA1 is well conserved in many plants <ref type="bibr">(Paik et al., 2019)</ref>, it is possible that the structural integrity of the kinase domain is important for its proper function, whereas the biochemical basis remains unknown. Our study shows that the kinase domain of SPA1 may act as a molecular scaffold for potential protein-protein interaction. We observed considerable HY5 accumulation in the SPA1 R517E line (Fig. <ref type="figure">3a</ref>), which explained the de-etiolation phenotype of SPA1 R517E mutant, showing photomorphogenesis in the dark. Moreover, the accumulation of HY5 in SPA1 R517E mutant in the dark resulting from the failure of degradation by COP1-SPA complex confirmed our hypothesis that the kinase domain of SPA1 might act as a molecular scaffold for protein-protein interaction.</p><p>Phosphorylation of transcription factors is a common modification that can influence their biological properties, such as multimerization or nucleocytoplasmic partitioning in both plants and animals. In plant photomorphogenesis, phosphorylation has been observed for many transcription factors <ref type="bibr">(Pham et al., 2018)</ref>. Other than PIF1, light can also induce phosphorylation of PIF3 at multiple sites, and phosphorylated PIF3 is subject to the degradation by light-responsive BTB protein (LRB) and EIN3-binding F box protein (EBF) E3 ligases <ref type="bibr">(Ni et al., 2013</ref><ref type="bibr">(Ni et al., , 2014;;</ref><ref type="bibr">Dong et al., 2017)</ref>. Phosphorylation can also regulate the transcriptional activity of PIF4, which affects diurnal hypocotyl elongation and also influences translocation of PIF7, which regulates shade-induced stem elongation (Bernardo-Garc &#305;a et al., 2014; Fig. <ref type="figure">9</ref> A model showing suppressor of phytochrome A-105 (SPA)-mediated phosphorylation of elongated hypocotyl5 (HY5) to fine-tune photomorphogenesis. In the dark (upper panel), constitutive photomorphogenic1 (COP1)-SPA protein complexes function as E3 ubiquitination ligases and interact preferentially with the unphosphorylated HY5 for ubiquitination and degradation by the 26S proteasome; thus, light-responsive genes are turned off, and seedlings show skotomorphogenesis. In addition, SPAs phosphorylate HY5, and the phosphorylated HY5 has less affinity for the COP1-SPA complex and is relatively more stable. Thus, seedlings can maintain a small pool of HY5 in the dark. Upon light irradiation (lower panel), the remaining phosphorylated HY5 (or potentially a dephosphorylated form) can rapidly activate light responses. COP1-SPA complex is also reorganized, reducing the E3 ligase activity of the COP1-SPA complex, thus stabilizing HY5 under light. COP1 is also excluded from the nucleus under prolonged light conditions (dashed arrow), thus stabilizing HY5 and other positive factors that promote photomorphogenesis. Unphosphorylated HY5 binds more efficiently to the promoters of downstream genes and promotes photomorphogenesis, whereas SPAs phosphorylate HY5 to avoid overphotomorphogenesis under light. <ref type="bibr">Huang et al., 2018)</ref>. In this study, we demonstrated that the phosphorylation of HY5 results in lower binding affinity to COP1 and SPA1, which reduces HY5 ubiquitination and, in turn, stabilizes HY5 proteins in the dark . Therefore, HY5 abundance is regulated apparently by two parallel pathways. One is the oscillation of the availability of COP1 in the nucleus, and the other is the specific phosphorylation of HY5, which modulates HY5's ability to interact with COP1-SPA complex. Considering that HY5 is a key positive regulator of photomorphogenesis at the early seedling stage, this mechanism may help maintain a small pool of less active HY5 in the dark so that seedlings can give a rapid initial response during dark-to-light transition. Thus, SPAs are acting both negatively and positively to regulate HY5 level and activity, forming a negative feedback loop between HY5 and COP1-SPA (Fig. <ref type="figure">9</ref>). This is consistent with a recent study showing that accumulation of HY5 in the dark leads to an increase in the COP1-SPA complex, and thus its own degradation <ref type="bibr">(Burko et al., 2020)</ref>.</p><p>Phosphorylation of transcription factors to regulate their stability and DNA binding capacity is common in eukaryotic cells <ref type="bibr">(Hunter, 2007)</ref>. Previous ChIP-chip analysis showed that HY5 binds directly to the promoters of genes related to auxin signaling, ethylene signaling, and GA signaling. Moreover, it was shown that HY5 is necessary for the rapid transcription of those genes during the dark-to-light transition, which eventually allows the accumulation of Chl and anthocyanin for photosynthesis <ref type="bibr">(Lee et al., 2007;</ref><ref type="bibr">Burko et al., 2020)</ref>. We show here that unphosphorylated HY5 has a stronger binding affinity to its target promoters, such as G-box and ACE-box in XTH15, EXP2, IAA19, CHS and SAUR36, than phosphorylated HY5 does (Fig. <ref type="figure">7a</ref>). This is consistent with the gene expression (Fig. <ref type="figure">7b</ref>) and phenotype of the HY5-S36A transgenic line, which shows shorter hypocotyl length than WT HY5 does (Fig. <ref type="figure">8</ref>). HY5 activity is also regulated by interaction with other transcription factors, including the BBX factors <ref type="bibr">(Song et al., 2020)</ref>. In fact, HY5 lacks any transcriptional activation domain. A recent study showed that interaction with BBX20/21/22 proteins is necessary for activation of gene expression by HY5 <ref type="bibr">(Bursch et al., 2020)</ref>. Whether phosphorylation of HY5 has any influence on interaction with other transcription factors awaits further studies.</p><p>In summary, the data presented here describe SPA proteins as the missing kinases for phosphorylation of HY5 (Fig. <ref type="figure">9</ref>). Thus, the COP1-SPA complex is acting both positively and negatively to regulate HY5 abundance and activity to fine-tune photomorphogenesis. Our data also show that, by modulating phosphorylation of HY5 and altering its protein stability and activity, plants can rapidly respond to light irradiation and also avoid overphotomorphogenesis, which would be of great advantage for seedlings in the constantly changing natural environment.   Table <ref type="table">S1</ref> Primer sequences used in experiments described in the text.</p><p>Please note: Wiley Blackwell are not responsible for the content or functionality of any Supporting Information supplied by the authors. Any queries (other than missing material) should be directed to the New Phytologist Central Office.</p><p>New Phytologist is an electronic (online-only) journal owned by the New Phytologist Foundation, a not-for-pro t organization dedicated to the promotion of plant science, facilitating projects from symposia to free access for our Tansley reviews and Tansley insights.</p><p>Regular papers, Letters, Viewpoints, Research reviews, Rapid reports and both Modelling/Theory and Methods papers are encouraged. We are committed to rapid processing, from online submission through to publication 'as ready' via Early Viewour average time to decision is &lt;26 days. There are no page or colour charges and a PDF version will be provided for each article.</p><p>The journal is available online at Wiley Online Library. Visit www.newphytologist.com to search the articles and register for table of contents email alerts.</p><p>If you have any questions, do get in touch with Central O ce (np-centralo ce@lancaster.ac.uk) or, if it is more convenient, our USA O ce (np-usao ce@lancaster.ac.uk) For submission instructions, subscription and all the latest information visit www.newphytologist.com</p></div></body>
		</text>
</TEI>
